Log in

OTCMKTS:NMTC - Neuroone Medical Technologies Stock Price, Forecast & News

+0.06 (+2.19 %)
(As of 12/6/2019 05:47 AM ET)
Today's Range
Now: $2.80
50-Day Range
MA: $2.27
52-Week Range
Now: $2.80
Volume22,353 shs
Average Volume10,940 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
NeuroOne Medical Technologies Corporation, an early-stage medical technology company, focuses on the development and commercialization of thin film electrode technology. The company develops cortical and sheet and depth electrode technology to provide continuous electroencephalogram and stereoelectroencephalography recording, brain stimulation, and ablation solutions for patients suffering from epilepsy, Parkinson's disease, dystonia, essential tremors, and other related brain related disorders. The company is based in Eden Prairie, Minnesota.

Industry, Sector and Symbol

Industry Medical Devices
Current SymbolOTCMKTS:NMTC



Sales & Book Value

Annual SalesN/A



Next Earnings DateN/A
OptionableNot Optionable

Receive NMTC News and Ratings via Email

Sign-up to receive the latest news and ratings for NMTC and its competitors with MarketBeat's FREE daily newsletter.

Neuroone Medical Technologies (OTCMKTS:NMTC) Frequently Asked Questions

What is Neuroone Medical Technologies' stock symbol?

Neuroone Medical Technologies trades on the OTCMKTS under the ticker symbol "NMTC."

Has Neuroone Medical Technologies been receiving favorable news coverage?

Headlines about NMTC stock have trended somewhat negative recently, according to InfoTrie Sentiment Analysis. InfoTrie rates the sentiment of press coverage by monitoring more than six thousand news and blog sources in real-time. The firm ranks coverage of companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Neuroone Medical Technologies earned a media sentiment score of -1.6 on InfoTrie's scale. They also assigned media coverage about the company a news buzz of 10.0 out of 10, indicating that recent press coverage is extremely likely to have an effect on the company's share price in the next few days. View News Stories for Neuroone Medical Technologies.

Who are some of Neuroone Medical Technologies' key competitors?

What other stocks do shareholders of Neuroone Medical Technologies own?

Who are Neuroone Medical Technologies' key executives?

Neuroone Medical Technologies' management team includes the folowing people:
  • Mr. David A. Rosa, CEO, Pres & Director (Age 55)
  • Mr. Mark Christianson, VP of Bus. Devel. & Marketing (Age 52)
  • Mr. Thomas Bachinski, Chief Devel. Officer (Age 58)
  • Mr. Steven Mertens, Chief Technology Officer (Age 56)
  • Mr. Scott Heuler, VP of Sales (Age 55)

How do I buy shares of Neuroone Medical Technologies?

Shares of NMTC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Neuroone Medical Technologies' stock price today?

One share of NMTC stock can currently be purchased for approximately $2.80.

What is Neuroone Medical Technologies' official website?

The official website for Neuroone Medical Technologies is http://www.originalsourcemusic.com/.

How can I contact Neuroone Medical Technologies?

Neuroone Medical Technologies' mailing address is 10006 Liatris Ln, EDEN PRAIRIE, MN 55347-1210, United States. The company can be reached via phone at +1-952-2377412.

MarketBeat Community Rating for Neuroone Medical Technologies (OTCMKTS NMTC)

Community Ranking:  2.7 out of 5 (star star)
Outperform Votes:  47 (Vote Outperform)
Underperform Votes:  39 (Vote Underperform)
Total Votes:  86
MarketBeat's community ratings are surveys of what our community members think about Neuroone Medical Technologies and other stocks. Vote "Outperform" if you believe NMTC will outperform the S&P 500 over the long term. Vote "Underperform" if you believe NMTC will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 12/6/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel